Juniper Pharma (NASDAQ: JNP) reported Q4 EPS of $0.88, $0.43 better than the analyst estimate of $0.45. Revenue for the quarter came in at $20.9 million versus the consensus estimate of $15.33 million.

For earnings history and earnings-related data on Juniper Pharma (JNP) click here.